Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7384

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-7384). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatinfigure1. (Atorvastatinfigure1)

Atorvastatinfigure1. (Atorvastatinfigure1)
Chemical structure of atorvastatin calcium, showing the molecular arrangement including calcium and water of crystallization components.*
FDA Label Image

Atorvastatinfigure2. (Atorvastatinfigure2)

Atorvastatinfigure2. (Atorvastatinfigure2)
A line chart comparing cumulative incidence percentages over a period of 3.5 years for Atorvastatin and placebo groups. The plot shows Atorvastatin having a lower cumulative incidence compared to placebo, with a hazard ratio and statistical significance noted below the x-axis.*
FDA Label Image

Atorvastatinfigure3. (Atorvastatinfigure3)

Atorvastatinfigure3. (Atorvastatinfigure3)
A line graph depicting cumulative hazard percentages over a five-year follow-up period, comparing atorvastatin and placebo. The x-axis shows time to the first primary endpoint from one through four years, and the y-axis shows cumulative hazard percentage. The atorvastatin group consistently displays a lower hazard rate than placebo, with a hazard ratio of 0.63 (0.48-0.83) and a p-value of 0.001.*
FDA Label Image

Atorvastatinfigure4. (Atorvastatinfigure4)

Atorvastatinfigure4. (Atorvastatinfigure4)
A line graph comparing the time to first major cardiovascular endpoint (in years) for Atorvastatin 10 mg and Atorvastatin 80 mg. The vertical axis shows the proportion of subjects experiencing the event, with Atorvastatin 80 mg trending below Atorvastatin 10 mg, indicating a lower event rate over time. The hazard ratio (HR) and confidence interval with p-value are displayed on the graph.*
FDA Label Image

Atorvastatinfigure9 (Atorvastatinfigure9)

FDA Label Image

Label Image (Lbl500907384)

Label Image (Lbl500907384)
Label for ATORVASTATIN CALCIUM 40 mg film-coated tablets by A-S Medication Solutions. The label states the dosage form as oral tablets, contains 30 tablets per package, and provides storage instructions to keep at 68 to 77 degrees Fahrenheit. The label includes the product NDC 50090-7384-0 and manufacturing location in Libertyville, Illinois.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.